124 related articles for article (PubMed ID: 31847167)
1. Dose-Limiting Organs at Risk in Carbon Ion Re-Irradiation of Head and Neck Malignancies: An Individual Risk-Benefit Tradeoff.
Held T; Harrabi SB; Lang K; Akbaba S; Windisch P; Bernhardt D; Rieken S; Herfarth K; Debus J; Adeberg S
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31847167
[No Abstract] [Full Text] [Related]
2. Carbon Ion Reirradiation for Recurrent Head and Neck Cancer: A Single-Institutional Experience.
Held T; Windisch P; Akbaba S; Lang K; El Shafie R; Bernhardt D; Plinkert P; Kargus S; Rieken S; Herfarth K; Debus J; Adeberg S
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):803-811. PubMed ID: 31349059
[TBL] [Abstract][Full Text] [Related]
3. Rare entities in head-and-neck cancer: salvage re-irradiation with carbon ions.
Held T; Windisch P; Akbaba S; Lang K; Farnia B; Liermann J; Bernhardt D; Plinkert P; Freudlsperger C; Rieken S; Herfarth K; Debus J; Adeberg S
Radiat Oncol; 2019 Nov; 14(1):202. PubMed ID: 31718670
[TBL] [Abstract][Full Text] [Related]
4. Dose painting for re-irradiation of head and neck cancer.
Skjøtskift T; Evensen ME; Furre T; Moan JM; Amdal CD; Bogsrud TV; Malinen E; Dale E
Acta Oncol; 2018 Dec; 57(12):1693-1699. PubMed ID: 30280623
[TBL] [Abstract][Full Text] [Related]
5. Semiautomated head-and-neck IMRT planning using dose warping and scaling to robustly adapt plans in a knowledge database containing potentially suboptimal plans.
Schmidt M; Lo JY; Grzetic S; Lutzky C; Brizel DM; Das SK
Med Phys; 2015 Aug; 42(8):4428-34. PubMed ID: 26233173
[TBL] [Abstract][Full Text] [Related]
6. Pulsed-Reduced Dose Rate (PRDR) Radiotherapy for Recurrent Primary Central Nervous System Malignancies: Dosimetric and Clinical Results.
Kutuk T; Tolakanahalli R; McAllister NC; Hall MD; Tom MC; Rubens M; Appel H; Gutierrez AN; Odia Y; Mohler A; Ahluwalia MS; Mehta MP; Kotecha R
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740612
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of Re-irradiation using carbon ions for recurrent head and neck malignancies after carbon-ion radiotherapy.
Hayashi K; Koto M; Ikawa H; Hagiwara Y; Tsuji H; Ogawa K; Kamada T
Radiother Oncol; 2019 Jul; 136():148-153. PubMed ID: 31015117
[TBL] [Abstract][Full Text] [Related]
8. Dose sparing of brainstem and spinal cord for re-irradiating recurrent head and neck cancer with intensity-modulated radiotherapy.
Chen CC; Lee CC; Mah D; Sharma R; Landau E; Garg M; Wu A
Med Dosim; 2011; 36(1):21-7. PubMed ID: 20202815
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
10. [Intensity-modulated radiation therapy for head and neck cancers with bilateral irradiation of the neck : preliminary results].
Lapeyre M; Marchesi V; Mege A; Aletti P; Graff P; Racadot S; Noel A; Marchal C
Cancer Radiother; 2004 Jun; 8(3):134-47. PubMed ID: 15217581
[TBL] [Abstract][Full Text] [Related]
11. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
[TBL] [Abstract][Full Text] [Related]
12. Improved VMAT planning for head and neck tumors with an advanced optimization algorithm.
Klippel N; Schmücking M; Terribilini D; Geretschläger A; Aebersold DM; Manser P
Z Med Phys; 2015 Dec; 25(4):333-340. PubMed ID: 26071076
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
14. Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients.
Cozzarini C; Fiorino C; Deantoni C; Briganti A; Fodor A; La Macchia M; Noris Chiorda B; Rancoita PM; Suardi N; Zerbetto F; Calandrino R; Montorsi F; Di Muzio N
Eur Urol; 2014 Dec; 66(6):1024-30. PubMed ID: 24985964
[TBL] [Abstract][Full Text] [Related]
15. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
[TBL] [Abstract][Full Text] [Related]
16. Impact of cervicothoracic region stereotactic spine radiosurgery on adjacent organs at risk.
Sharma M; Bennett EE; Rahmathulla G; Chao ST; Koech HK; Gregory SN; Emch T; Magnelli A; Meola A; Suh JH; Angelov L
Neurosurg Focus; 2017 Jan; 42(1):E14. PubMed ID: 28041323
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903
[TBL] [Abstract][Full Text] [Related]
18. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
Murrell DH; Laba JM; Erickson A; Millman B; Palma DA; Louie AV
Radiat Oncol; 2018 Apr; 13(1):57. PubMed ID: 29606150
[TBL] [Abstract][Full Text] [Related]
20. Organs at risk's tolerance and dose limits for head and neck cancer re-irradiation: A literature review.
Dionisi F; Fiorica F; D'Angelo E; Maddalo M; Giacomelli I; Tornari E; Rosca A; Vigo F; Romanello D; Cianchetti M; Tommasino F; Massaccesi M; Orlandi E
Oral Oncol; 2019 Nov; 98():35-47. PubMed ID: 31536844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
